Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases

Introduction: Clinical evidence shows that opioid administration in cancer patients is associated with shorter survival. This study explored the impact of opioid requirement on overall survival of patients with spinal metastases. We also evaluated the association between opioid requirement and tumor...

Full description

Bibliographic Details
Main Authors: Sho Dohzono, Ryuichi Sasaoka, Kiyohito Takamatsu, Hiroaki Nakamura
Format: Article
Language:English
Published: The Japanese Society for Spine Surgery and Related Research 2023-05-01
Series:Spine Surgery and Related Research
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/ssrr/7/3/7_2021-0169/_pdf/-char/en
_version_ 1797804045071548416
author Sho Dohzono
Ryuichi Sasaoka
Kiyohito Takamatsu
Hiroaki Nakamura
author_facet Sho Dohzono
Ryuichi Sasaoka
Kiyohito Takamatsu
Hiroaki Nakamura
author_sort Sho Dohzono
collection DOAJ
description Introduction: Clinical evidence shows that opioid administration in cancer patients is associated with shorter survival. This study explored the impact of opioid requirement on overall survival of patients with spinal metastases. We also evaluated the association between opioid requirement and tumor-related spinal instability. Methods: We retrospectively identified 428 patients who had been diagnosed with spinal metastases from February 2009 to May 2017. Those with an opioid prescription during the first 1 month after the diagnosis were included in this study. Patients given opioids were divided into two groups: the opioid requirement group [5 mg oral morphine equivalent (OME)/day] and the nonopioid group (<5 mg OME/day). Spinal instability due to metastases was evaluated using the Spinal Instability Neoplastic Score (SINS). Cox proportional hazards analysis was performed to evaluate the relationship between opioid use and overall survival. Results: The most frequent primary cancer site was the lung, in 159 patients (37%), followed by the breast in 75 (18%) and the prostate in 46 (11%). Multivariate analyses showed that patients who required 5 mg OME/day were approximately twofold more likely to die after a spinal metastases diagnosis than those who required <5 mg OME/day (hazard ratio 2.13; 95% confidence interval 1.69-2.67; p<0.001). The SINS was significantly higher in the opioid requirement group than those in the nonopioid group (p<0.001). Conclusions: For patients with spinal metastases, opioid requirement was associated with shorter survival, independently of known prognostic factors. The patients were also more likely to have tumor-related spinal instability than those in the nonopioid group.
first_indexed 2024-03-13T05:30:15Z
format Article
id doaj.art-3098e6e6bb344795b7eb9471571ddff6
institution Directory Open Access Journal
issn 2432-261X
language English
last_indexed 2024-03-13T05:30:15Z
publishDate 2023-05-01
publisher The Japanese Society for Spine Surgery and Related Research
record_format Article
series Spine Surgery and Related Research
spelling doaj.art-3098e6e6bb344795b7eb9471571ddff62023-06-15T01:33:21ZengThe Japanese Society for Spine Surgery and Related ResearchSpine Surgery and Related Research2432-261X2023-05-017323524110.22603/ssrr.2021-01692021-0169Association between Opioid Requirement and Overall Survival in Patients with Spinal MetastasesSho Dohzono0Ryuichi Sasaoka1Kiyohito Takamatsu2Hiroaki Nakamura3Department of Orthopaedic Surgery, Yodogawa Christian HospitalDepartment of Orthopaedic Surgery, Yodogawa Christian HospitalDepartment of Orthopaedic Surgery, Yodogawa Christian HospitalDepartment of Orthopaedic Surgery, Osaka Metropolitan University Graduate School of MedicineIntroduction: Clinical evidence shows that opioid administration in cancer patients is associated with shorter survival. This study explored the impact of opioid requirement on overall survival of patients with spinal metastases. We also evaluated the association between opioid requirement and tumor-related spinal instability. Methods: We retrospectively identified 428 patients who had been diagnosed with spinal metastases from February 2009 to May 2017. Those with an opioid prescription during the first 1 month after the diagnosis were included in this study. Patients given opioids were divided into two groups: the opioid requirement group [5 mg oral morphine equivalent (OME)/day] and the nonopioid group (<5 mg OME/day). Spinal instability due to metastases was evaluated using the Spinal Instability Neoplastic Score (SINS). Cox proportional hazards analysis was performed to evaluate the relationship between opioid use and overall survival. Results: The most frequent primary cancer site was the lung, in 159 patients (37%), followed by the breast in 75 (18%) and the prostate in 46 (11%). Multivariate analyses showed that patients who required 5 mg OME/day were approximately twofold more likely to die after a spinal metastases diagnosis than those who required <5 mg OME/day (hazard ratio 2.13; 95% confidence interval 1.69-2.67; p<0.001). The SINS was significantly higher in the opioid requirement group than those in the nonopioid group (p<0.001). Conclusions: For patients with spinal metastases, opioid requirement was associated with shorter survival, independently of known prognostic factors. The patients were also more likely to have tumor-related spinal instability than those in the nonopioid group.https://www.jstage.jst.go.jp/article/ssrr/7/3/7_2021-0169/_pdf/-char/encancerspinal metastasesprognosisopioidspinal instability
spellingShingle Sho Dohzono
Ryuichi Sasaoka
Kiyohito Takamatsu
Hiroaki Nakamura
Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases
Spine Surgery and Related Research
cancer
spinal metastases
prognosis
opioid
spinal instability
title Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases
title_full Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases
title_fullStr Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases
title_full_unstemmed Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases
title_short Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases
title_sort association between opioid requirement and overall survival in patients with spinal metastases
topic cancer
spinal metastases
prognosis
opioid
spinal instability
url https://www.jstage.jst.go.jp/article/ssrr/7/3/7_2021-0169/_pdf/-char/en
work_keys_str_mv AT shodohzono associationbetweenopioidrequirementandoverallsurvivalinpatientswithspinalmetastases
AT ryuichisasaoka associationbetweenopioidrequirementandoverallsurvivalinpatientswithspinalmetastases
AT kiyohitotakamatsu associationbetweenopioidrequirementandoverallsurvivalinpatientswithspinalmetastases
AT hiroakinakamura associationbetweenopioidrequirementandoverallsurvivalinpatientswithspinalmetastases